EMA Enlists GPs’ Help To Generate More Real-World Evidence

The generation of more real world evidence on medicines is one of the aims of a newly announced collaboration that will see family doctors playing a bigger role in providing data for the European Medicines Agency to use in its drug evaluation activities.

Young Doctor With Digital Tablet — The EMA is seeking more family doctor input into its regulatory activities

The European Medicines Agency and bodies representing family doctors in Europe are to strengthen their links in a move aimed at producing more evidence on how medicines are used in the clinical setting and feeding that knowledge into the EMA’s drug evaluation activities.

The collaboration will be underpinned by an action plan to 2020 that aims to involve general practitioners and family physicians...